The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), awarded a firm fixed-price purchase order valued at $11,400.00 to Adaptive Biotechnologies Corporation (doing business as Adaptive) for DNA extraction services, including deep and survey sequencing. The contract does not have a set-aside designation. Adaptive Biotechnologies is a commercial provider of immune-driven medicine services and products that has...
This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, to Adaptive Biotechnologies Corporation (also doing business as Adaptive) for IMMUNOSEQ MMTCRB SERVICE. The contract, valued at $12,200.00, does not have a set-aside designation. Through this award, Adaptive Biotechnologies will provide specialized sequencing and testing services to support HHS research programs. Adaptive...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $14,690 firm fixed-price purchase order to Adaptive Biotechnologies Corporation (doing business as Adaptive) for ImmunoSEQ sequencing services. The contract has an ultimate completion date of December 20, 2024. Adaptive is a commercial provider of immune-driven medicine services and products, and has previously received federal contracts and grants from the Department of Health and Human Services (HHS), Department...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Adaptive Biotechnologies Corporation ("Adaptive") for immunosequencing extraction services. The $12,750 contract was awarded on December 10, 2019 with a completion date of December 10, 2020. Adaptive is a commercial provider of immune-driven medicine services and products. The company has...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $5,900 purchase order to Akesogen, Inc.'s Tempus Labs, Inc. Division for DNA extraction from whole blood. The firm fixed price contract will be performed in Bethesda, Maryland over a one month period concluding in mid-February 2016. No set aside designation or subcontractors were indicated. The award supports the funding agency's biomedical research...
This is a $12,300 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Adaptive Biotechnologies Corporation (Adaptive) for "IMMUNOSEQ MMTCRB SEQUENCING SERVICE". The contract has an ultimate completion date of December 31, 2023 and was awarded on September 19, 2023 without a set-aside designation. Adaptive, a for-profit organization, has previously...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to DNA Genotek Inc., a manufacturer of DNA collection and analysis products. The contract is for the provision of 430 units of the AMBIS 1691328 FULL 4ML DNA EXTRACTION FROM SALIVA SAMPLES kit at a unit price of $25, for a total ceiling value of $12,900.00. The contract has a completion date of September 8, 2014 and does not...
This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $13,943.66 firm fixed price delivery order is for reagents to support next-generation sequencing experiments in Dr. Calvo's laboratory. There is no set-aside designation for this contract. Illumina has previously received prime federal contracts and subcontracts from agencies such as the NIH, Centers...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $49,684.25 firm fixed price delivery order to Illumina, Inc. for a NEXTSEQ 500/550 HIGH OUTPUT KIT V2.5 (300 CYCLES). The place of performance is San Diego, California. Illumina will provide the sequencing kit to support genomic analysis at the NIH Clinical Center under this contract with no set-aside designation. As the sole manufacturer of the NextSeq sequencing platform, Illumina is uniquely...
This $13,447.16 firm fixed price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract is to provide a NextSeq DNA library preparation kit and related consumables to support nucleic acid sequencing capabilities at the Naval Health Research Center's Biological Defense Research Directorate in San Diego, California. The award is not associated with a larger...